Variability of Physical Assessments in an Older Population That is Overweight or Obese

December 13, 2021 updated by: Versanis Bio, Inc.

An Observational Study to Assess the Feasibility and Variability of Physical Assessments Performed by People 45 Years of Age or Older Who Are Overweight or Obese

Variability of physical assessments in an older population that is overweight or obese.

Study Overview

Detailed Description

The purpose of this study is to understand difficulty in obtaining physical assessment measurements and assess the variability of these assessments when performed by people who are overweight or obese. Data collected in this protocol will be used to inform the design of future clinical studies.

Study Type

Observational

Enrollment (Actual)

58

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Jacksonville, Florida, United States, 32256
        • CNS Healthcare
      • Orlando, Florida, United States, 32801
        • CNS Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Approximately 60 male and female participants 45 years of age or older who are overweight or obese will be enrolled. To ensure data are collected from a wide age range, 20 participants will be enrolled per specified age ranges. The study population must include at least 40% females in the overall study.

Description

Inclusion Criteria:

  • A written informed consent must be obtained before any study-related assessment is conducted.
  • Men and women aged ≥ 45.
  • BMI ≥ 30 or BMI ≥ 27 with one or more obesity-associated comorbidities (e.g. hypertension, cardiovascular disease, hyperlipidemia, elevated fasting blood sugar levels, sleep apnea).
  • Participants must be able to communicate well with the Investigator and comply with the study requirements.

Exclusion Criteria:

  • Participant weight > 150 kg.
  • Systolic blood pressure < 90 or > 180 or diastolic blood pressure <50 or >100.
  • Heart rate ≤ 50 or ≥ 100.
  • Unstable medical condition that would put the participant at risk by performing the study assessments.
  • Chronic medical condition rendering participants unable to perform the assessment, e.g., severe knee osteoarthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Age Range 45 to </= 60
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.
Age Range 61 to </= 75
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.
Age >/= 76
The SPPB includes balance stands, a 4-meter walk and 5 timed chair stands.
The 30CST measures the number of times a person can rise from a seated to standing position within 30 seconds.
Grip strength is used as a marker of overall muscle strength.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To assess the variability of Short Physical Performance Battery (SPPB, scored from 0-12) results within and between participants.
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)
To assess the variability of the 30 Second Chair Stand (30CST) results within and between participants.
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)
To assess the variability of grip strength results (kg) with the use of a hand grip dynamometer within and between participants.
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)
To assess the variability of the individual Short Physical Performance Battery (SPPB) with subsets (subsets of Balance, Gait and Chair Stand scored 0-4) within participants.
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)
To compare the variability between the 5 Repetition Sit to Stand (5STS) subtest of the SPPB and 30CST.
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)
To assess the correlation between bioelectrical impedance analysis (BIA) and waist circumference (WC) as well as body mass index (BMI).
Time Frame: Baseline (+7 day window)
Baseline (+7 day window)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2021

Primary Completion (Actual)

November 5, 2021

Study Completion (Actual)

November 5, 2021

Study Registration Dates

First Submitted

November 5, 2021

First Submitted That Met QC Criteria

December 13, 2021

First Posted (Actual)

January 3, 2022

Study Record Updates

Last Update Posted (Actual)

January 3, 2022

Last Update Submitted That Met QC Criteria

December 13, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VER201-OBS-032

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Short Performance Physical Battery (SPPB Test)

Subscribe